These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18815033)

  • 1. Recent progress with FKBP-derived destabilizing domains.
    Chu BW; Banaszynski LA; Chen LC; Wandless TJ
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5941-4. PubMed ID: 18815033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of the Hsp90-binding FKBP immunophilins.
    Guy NC; Garcia YA; Sivils JC; Galigniana MD; Cox MB
    Subcell Biochem; 2015; 78():35-68. PubMed ID: 25487015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction.
    Linnert M; Lin YJ; Manns A; Haupt K; Paschke AK; Fischer G; Weiwad M; Lücke C
    Biochemistry; 2013 Mar; 52(12):2097-107. PubMed ID: 23418784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule displacement of a cryptic degron causes conditional protein degradation.
    Bonger KM; Chen LC; Liu CW; Wandless TJ
    Nat Chem Biol; 2011 Jul; 7(8):531-7. PubMed ID: 21725303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolving the functions of peptidylprolyl isomerases: insights from the mutagenesis of the nuclear FKBP25 enzyme.
    Gudavicius G; Soufari H; Upadhyay SK; Mackereth CD; Nelson CJ
    Biochem Soc Trans; 2013 Jun; 41(3):761-8. PubMed ID: 23697935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and analysis of stabilizing ligands for FKBP-derived destabilizing domains.
    Grimley JS; Chen DA; Banaszynski LA; Wandless TJ
    Bioorg Med Chem Lett; 2008 Jan; 18(2):759-61. PubMed ID: 18039574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.
    Banaszynski LA; Chen LC; Maynard-Smith LA; Ooi AG; Wandless TJ
    Cell; 2006 Sep; 126(5):995-1004. PubMed ID: 16959577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
    Monaghan P; Bell A
    Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific and rapid labeling of cell surface proteins with recombinant FKBP-fused fluorescent proteins.
    Zhang X; Deng Y; Chang H; Ji C; Zhang M; Peng J; Xu T; Xu P
    Protein Cell; 2014 Oct; 5(10):800-3. PubMed ID: 25109944
    [No Abstract]   [Full Text] [Related]  

  • 11. Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design.
    LeMaster DM; Hernandez G
    Curr Mol Pharmacol; 2015; 9(1):5-26. PubMed ID: 25986571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial regulation of p53 function by modulating its assembly.
    Inobe T; Nozaki M; Nukina N
    Biochem Biophys Res Commun; 2015 Nov; 467(2):322-7. PubMed ID: 26454170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating cell surface glycosylation with a small-molecule switch.
    Dube DH; de Graffenried CL; Kohler JJ
    Methods Enzymol; 2006; 415():213-29. PubMed ID: 17116477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting FKBP isoforms with small-molecule ligands.
    Blackburn EA; Walkinshaw MD
    Curr Opin Pharmacol; 2011 Aug; 11(4):365-71. PubMed ID: 21803654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein.
    Andrianov AM
    J Biomol Struct Dyn; 2008 Aug; 26(1):49-56. PubMed ID: 18533725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the FKBP.rapamycin.FRB ternary complex.
    Banaszynski LA; Liu CW; Wandless TJ
    J Am Chem Soc; 2005 Apr; 127(13):4715-21. PubMed ID: 15796538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of Plasmodium vivax FK506-binding protein 25 reveals conformational changes responsible for its noncanonical activity.
    Rajan S; Austin D; Harikishore A; Nguyen QT; Baek K; Yoon HS
    Proteins; 2014 Jul; 82(7):1235-44. PubMed ID: 24302348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A charge-sensitive loop in the FKBP38 catalytic domain modulates Bcl-2 binding.
    Maestre-Martínez M; Haupt K; Edlich F; Neumann P; Parthier C; Stubbs MT; Fischer G; Lücke C
    J Mol Recognit; 2011; 24(1):23-34. PubMed ID: 20140889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR solution structure and dynamics of the peptidyl-prolyl cis-trans isomerase domain of the trigger factor from Mycoplasma genitalium compared to FK506-binding protein.
    Vogtherr M; Jacobs DM; Parac TN; Maurer M; Pahl A; Saxena K; Rüterjans H; Griesinger C; Fiebig KM
    J Mol Biol; 2002 May; 318(4):1097-115. PubMed ID: 12054805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a plant immunophilin domain involved in regulation of MDR-type ABC transporters.
    Weiergräber OH; Eckhoff A; Granzin J
    FEBS Lett; 2006 Jan; 580(1):251-5. PubMed ID: 16364310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.